PALI Fundamental Analysis - PALISADES GOLDCORP LTD

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to PALI. PALI was compared to 81 industry peers in the Capital Markets industry. PALI has only an average score on both its financial health and profitability. PALI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

PALI had positive earnings in the past year.
In the past year PALI has reported a negative cash flow from operations.
In multiple years PALI reported negative net income over the last 5 years.
PALI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PALI's Return On Assets of 15.03% is amongst the best of the industry. PALI outperforms 82.72% of its industry peers.
With an excellent Return On Equity value of 20.56%, PALI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
With an excellent Return On Invested Capital value of 33.97%, PALI belongs to the best of the industry, outperforming 96.30% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	15.03%
ROE	20.56%
ROIC	33.97%

ROA(3y)-47.42%

ROA(5y)-16.52%

ROE(3y)-60.46%

ROE(5y)-19.18%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Profit Margin value of 30.36%, PALI is doing good in the industry, outperforming 71.60% of the companies in the same industry.
PALI's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 95.22%, PALI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 99.97%, PALI belongs to the top of the industry, outperforming 98.77% of the companies in the same industry.
PALI's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	95.22%
PM (TTM)	30.36%
GM	99.97%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-7.55%

PM growth 5YN/A

GM growth 3Y1.22%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for PALI has been reduced compared to 1 year ago.
There is no outstanding debt for PALI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PALI has an Altman-Z score of 4.90. This indicates that PALI is financially healthy and has little risk of bankruptcy at the moment.
PALI has a Altman-Z score of 4.90. This is in the better half of the industry: PALI outperforms 79.01% of its industry peers.
PALI has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PALI (0.09) is better than 72.84% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.09
Debt/FCF	N/A
Altman-Z	4.9

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

PALI has a Current Ratio of 14.48. This indicates that PALI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 14.48, PALI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
A Quick Ratio of 14.48 indicates that PALI has no problem at all paying its short term obligations.
PALI's Quick ratio of 14.48 is amongst the best of the industry. PALI outperforms 88.89% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	14.48
Quick Ratio	14.48

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 115.75% over the past year.
Looking at the last year, PALI shows a very strong growth in Revenue. The Revenue has grown by 5317.21%.

EPS 1Y (TTM)115.75%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%1309.91%

Revenue 1Y (TTM)5317.21%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%8043.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.30 indicates a reasonable valuation of PALI.
PALI's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of PALI to the average of the S&P500 Index (27.32), we can say PALI is valued rather cheaply.

		Industry Rank	Sector Rank
PE	11.3
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for PALI!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

PALISADES GOLDCORP LTD

TSX-V:PALI (1/21/2026, 7:00:00 PM)

2.26

-0.23 (-9.24%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.21%

Inst Owner ChangeN/A

Ins Owners46.39%

Ins Owner ChangeN/A

Market Cap145.70M

Revenue(TTM)126.35M

Net Income(TTM)38.35M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	11.3
Fwd PE	N/A
P/S	1.15
P/FCF	N/A
P/OCF	N/A
P/B	0.78
P/tB	0.78
EV/EBITDA	N/A

EPS(TTM)0.2

EY8.85%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.16

FCFYN/A

OCF(TTM)-0.16

OCFYN/A

SpS1.96

BVpS2.89

TBVpS2.89

PEG (NY)N/A

PEG (5Y)N/A

Graham Number3.61

Profitability

		Industry Rank	Sector Rank
ROA	15.03%
ROE	20.56%
ROCE	50.49%
ROIC	33.97%
ROICexc	732.46%
ROICexgc	732.46%
OM	95.22%
PM (TTM)	30.36%
GM	99.97%
FCFM	N/A

ROA(3y)-47.42%

ROA(5y)-16.52%

ROE(3y)-60.46%

ROE(5y)-19.18%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-7.55%

PM growth 5YN/A

GM growth 3Y1.22%

GM growth 5YN/A

F-Score5

Asset Turnover0.5

Health

		Industry Rank	Sector Rank
Debt/Equity	0.09
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	1972.33
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	14.48
Quick Ratio	14.48
Altman-Z	4.9

F-Score5

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)115.75%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%1309.91%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)5317.21%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%8043.75%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y48550.2%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-4497.57%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-4497.57%

OCF growth 3YN/A

OCF growth 5YN/A

PALISADES GOLDCORP LTD / PALI.CA FAQ

What is the ChartMill fundamental rating of PALISADES GOLDCORP LTD (PALI.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PALI.CA.

Can you provide the valuation status for PALISADES GOLDCORP LTD?

ChartMill assigns a valuation rating of 1 / 10 to PALISADES GOLDCORP LTD (PALI.CA). This can be considered as Overvalued.

How profitable is PALISADES GOLDCORP LTD (PALI.CA) stock?

PALISADES GOLDCORP LTD (PALI.CA) has a profitability rating of 5 / 10.

How financially healthy is PALISADES GOLDCORP LTD?

The financial health rating of PALISADES GOLDCORP LTD (PALI.CA) is 6 / 10.

PALISADES GOLDCORP LTD (PALI.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PALISADES GOLDCORP LTD / PALI.CA FAQ

What is the ChartMill fundamental rating of PALISADES GOLDCORP LTD (PALI.CA) stock?

Can you provide the valuation status for PALISADES GOLDCORP LTD?

How profitable is PALISADES GOLDCORP LTD (PALI.CA) stock?

How financially healthy is PALISADES GOLDCORP LTD?